Skip to content
Catalyst

caffeineFinding

Caffeine decreases tumour necrosis factor alpha concentration

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“TNF-α at 38 weeks was 23% lower in the caffeine group compared to placebo, adjusting for baseline and covariates (P < 0.02, Table 3).”
Quoted verbatim from Intermittent hypoxia and caffeine in infants born preterm: the ICAF Randomized Clinical Trial.
This finding among the 76 findings on its endpoint

caffeine

Tumour necrosis factor alpha concentration

lowers

Who
very preterm infants (<=30 weeks + 6 days gestational age) randomised to extended caffeine therapy through 42 weeks 6 days PMA vs placebo; secondary endpoint
Dose studied
caffeine base 5 mg/kg/day once daily, escalating to 5 mg/kg twice daily at 36 weeks PMA, continued through 42 weeks 6 days PMA

Moderate evidencePMID 41285561 · 2026

02 · The study

Study
RCT
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3P35025S6MM09K7GCFVTC0D